Conditions: Chronic Idiopathic Constipation
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 459
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate a daily dose of BLI400 Laxative for safety and efficacy versus lubiprostone in constipated adults.

Detailed description:

Arms:
arm 1: 21 gm BLI400 powder arm 2: 24 mcg capsule bid

Interventions: intervention 1: BLI400 Laxative intervention 2: Lubiprostone
Intervention descriptions: intervention 1: 21 gm BLI400 powder intervention 2: 24 mcg capsule bid

Protocol document: